In addition, CoREST inhibition blocks breast tumor cell growth and metastasis of both endocrine-sensitive and endocrine-resistant xenografts largely by inhibiting a gene signature associated with tumor invasiveness in patients (17). This evidence concerns the gene RCOR1 and neoplasm.